Additionally, pretreatment with amyloid Aβ peptide in Alzheimer’s disease model, Sig-1R agonist OZP002 significantly lessened expression level of Bax in mouse hippocampus (Maurice et al., 2019). The gene discussed is SIGMAR1; the disease is Alzheimer disease.